PARIS, FRANCE – Interactomics pioneer Depixus is proud to announce they have been selected for the prestigious Innovation AveNEW showcase at the Society for Laboratory Automation and Screening (SLAS) International Conference & Exhibition, to be held in Boston from 3rd-7th February 2024.
Designed to highlight exciting companies providing game-changing technologies for the life sciences, the Innovation AveNEW is a dedicated area for Depixus to present their groundbreaking MAGNA™ technology to an international audience of customers and partners. The event will also serve as the launch of the company’s first consumer instrument, MAGNA One™.
Based on magnetic force spectroscopy, MAGNA One™ enables high-throughput analysis of dynamic biomolecular interactions – for example, between DNA, RNA, proteins and small molecules – in near-real time with single molecule resolution. The insights gained from MAGNA One™ will enable researchers to decode disease mechanisms and accelerate the development of new, more effective therapeutics.
Depixus CEO and President Gordon Hamilton says, “We’re delighted to have been selected as just one of 16 cutting edge companies to take part in the 2024 Innovation AveNEW program. The SLAS Conference is the world’s leading showcase for innovative technologies that are accelerating progress in the life sciences, and we can’t wait to bring MAGNA™ to the global stage.”